Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Arthroscopic Techniques
Case Report
Current Issue
Editorial
Elbow, Review Article
Foot and Ankle, Review Article
Guest Editorial
Hip, Review Article
Knee, Review Article
Letter to the Editor
Media and news
Narrative Review
Original Article
Regenerative Orthopaedics, Review Article
Retrospective and Prospective Studies
Review Article
Shoulder, Review Article
Spine, Review Article
Systematic Review and Meta-analysis
Video of Arthroscopic Surgical Procedures
Wrist, Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Arthroscopic Techniques
Case Report
Current Issue
Editorial
Elbow, Review Article
Foot and Ankle, Review Article
Guest Editorial
Hip, Review Article
Knee, Review Article
Letter to the Editor
Media and news
Narrative Review
Original Article
Regenerative Orthopaedics, Review Article
Retrospective and Prospective Studies
Review Article
Shoulder, Review Article
Spine, Review Article
Systematic Review and Meta-analysis
Video of Arthroscopic Surgical Procedures
Wrist, Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Arthroscopic Techniques
Case Report
Current Issue
Editorial
Elbow, Review Article
Foot and Ankle, Review Article
Guest Editorial
Hip, Review Article
Knee, Review Article
Letter to the Editor
Media and news
Narrative Review
Original Article
Regenerative Orthopaedics, Review Article
Retrospective and Prospective Studies
Review Article
Shoulder, Review Article
Spine, Review Article
Systematic Review and Meta-analysis
Video of Arthroscopic Surgical Procedures
Wrist, Review Article
View/Download PDF

Translate this page into:

Case Report
ARTICLE IN PRESS
doi:
10.25259/JASSM_24_2025

Factor V Leiden thrombophilia with acute pulmonary embolism in an operated arthroscopic anterior cruciate ligament with medial collateral ligament reconstruction: A rare case report

Department of Orthopaedics, Baby Memorial Hospital, Kannur, Kerala, India
Department of Orthopaedics, Dhanalakshmi Srinivasan Medical College and Hospital, Perambalur, Tamil Nadu, India
Department of Critical Care, Baby Memorial Hospital, Kannur, Kerala, India.

*Corresponding author: S. Venkatesh Kumar, Department of Orthopaedics, Dhanalakshmi Srinivasan Medical College and Hospital, Perambalur, Tamil Nadu, India. mailvenkatesh91@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Jyothiprasanth M, Venkatesh Kumar S, Aghosh MC, Rayees AK. Factor V Leiden thrombophilia with acute pulmonary embolism in an operated arthroscopic anterior cruciate ligament with medial collateral ligament reconstruction: A rare case report. J Arthrosc Surg Sports Med. doi: 10.25259/JASSM_24_2025

Abstract

The Factor V Leiden (FVL) mutation is a common genetic thrombophilia primarily affecting individuals of Caucasian descent. The heterozygous variation is frequently associated with a significantly increased risk of venous thromboembolism. This document presents a unique case of acute pulmonary embolism (PE) in a young child with a heterozygous FVL mutation following arthroscopic anterior cruciate ligament (ACL) surgery. A 35-year-old male with no prior thrombotic history underwent arthroscopic ACL and medial collateral ligament (MCL) reconstruction and arrived 1 week postoperatively with significant dyspnea and altered mental status. He was diagnosed with cardiac arrest and severe bilateral PE. The patient was administered intravenous tenecteplase for thrombolysis and thereafter admitted to the intensive care unit. The analysis of the FVL mutation identified a heterozygous mutation, with no additional significant thrombophilic mutations seen. Apixaban was administered for extended anticoagulation after stabilization. The patient demonstrated consistent clinical progress and was discharged in a stable condition with advisories for ongoing renal management and hematologic surveillance. This case report underscores the importance of assessing hereditary thrombophilia in post-operative thrombotic events, even in low-risk patients, and demonstrates the critical role of prompt identification and early management in improving outcomes.

Keywords

Factor V Leiden mutation
Heterozygous mutation
Massive acute pulmonary embolism
Post-arthroscopic anterior cruciate ligament and MCL reconstruction
South Indian patient

INTRODUCTION

Arthroscopic anterior cruciate ligament (ACL) reconstruction is among the most prevalent orthopedic surgical interventions and is regarded as a safe treatment with minimal complication rates. Numerous case reports documented venous thromboembolism (VTE) following arthroscopic ACL surgery.[1] Nonetheless, findings of Factor V Leiden (FVL) thrombophilia associated with acute pulmonary embolism (PE) following arthroscopic ACL surgery are unprecedented. Heterozygous FVL impacts 5% of Caucasians, predominantly Northern Europeans and individuals from the Middle East. Hispanics, Asians, Africans, and Native Americans infrequently possess FVL.[2] FVL elevates the risk of deep vein thrombosis (DVT), with or without PE.[3] We present a rare instance of a heterozygous mutation in the factor V gene, manifested as acute PE in a South Indian patient following arthroscopic ACL and MCL reconstruction.

CASE REPORT

A 35-year-old male patient with a recent history of ACL injury (January 10, 2025) for which arthroscopic ACL and MCL reconstruction was done on January 14, 2025 [Figure 1], presented initially to our hospital emergency department one week after surgery (January 20, 2025) with complaints of breathlessness and altered mental status and was diagnosed to be in cardiac arrest, and advanced cardiac life support (ACLS) protocol was initiated immediately. The patient had no comorbidity or risk factor for DVT or PE before this incident. A computed tomography (CT) pulmonary angiography was performed, showing PE in both the main left and right pulmonary arteries [Figure 2]. The patient was subsequently thrombolyzed with tenecteplase (40 mg IV).

X-ray left knee, anteroposterior (Left side) and lateral view (Right side), post anterior cruciate ligament and medial collateral ligament reconstruction surgery.
Figure 1:
X-ray left knee, anteroposterior (Left side) and lateral view (Right side), post anterior cruciate ligament and medial collateral ligament reconstruction surgery.
Computed tomography pulmonary angiography showing acute pulmonary thromboembolism with a large clot (red arrow).
Figure 2:
Computed tomography pulmonary angiography showing acute pulmonary thromboembolism with a large clot (red arrow).

CLINICAL ASSESSMENT

The patient is currently intubated with a Glasgow Coma Scale score of E1M3Vt. Vital signs show a blood pressure of 128/70 mmHg with ongoing support from noradrenaline, vasopressin, and adrenaline. The pulse rate is 102 beats/min, and the respiratory rate is 26 breaths/min. Pupils are bilaterally reactive to light. The patient is on 30% FiO2 in pressure-regulated volume control mode. The patient experienced another episode of cardiac arrest during the intensive care unit stay; two cycles of CPR achieved the return of spontaneous circulation.

Diagnostic assessment

A contrast-enhanced CT of the abdomen was performed, which was suggestive of a possible celiac trunk bleed. A diagnostic abdominal aortogram, along with an angiogram, revealed no evidence of active contrast extravasation. Initial laboratory investigations showed worsening renal function, elevated transaminases, and increased creatine phosphokinase levels.

On January 23, 2025, an ultrasonography of the abdomen showed that both kidneys had a higher-than-normal echotexture but still had a clear distinction between the outer and inner parts. A venous Doppler study performed that same day revealed no signs of DVT. A CT thorax conducted on January 28, 2025, indicated moderate bilateral pleural effusion with collapsed consolidations. We also noted a dilated main pulmonary artery, which is indicative of pulmonary artery hypertension. Finally, an echocardiogram on February 10, 2025, revealed no regional wall motion abnormalities, normal left ventricular systolic function, and an ejection fraction of 64%. FVL mutation analysis using real-time polymerase chain reaction revealed a heterozygous mutation in the Factor V gene. No mutations were detected in the prothrombin gene or the methylenetetrahydrofolate reductase gene.

Management

The patient was initiated on renal replacement therapy (RRT) due to worsening acute kidney injury. Subsequently, the patient developed melena and a drop in hemoglobin levels. We obtained a gastroenterology consultation and managed the condition conservatively. The patient received intravenous heparin, intravenous antibiotics, N-acetylcysteine, intravenous proton pump inhibitors, RRT, antipsychotics, and other supportive measures. Cardiology recommended starting apixaban with instructions to monitor hemoglobin levels.

Outcome and follow-up

We counseled the patient about the need for extended hemodialysis support. At present, the patient is clinically and hemodynamically stable, and consequently discharged.

DISCUSSION

Although many case reports on VTE following arthroscopic ACL surgery,[1,4,5] this is the first case report on FVL thrombophilia associated with acute PE following arthroscopic ACL surgery. The likelihood of VTE episodes may be heightened in arthroscopic ACL repair compared to meniscectomy, which is deemed less invasive and does not necessitate osseous drilling.[5]

FVL results from a mutation in the factor V gene. The mutated FVL exhibits resistance to activated protein C (APC). Consequently, APC is incapable of inhibiting FVL’s production of fibrin. Upon activation, FVL diminishes coagulation at a slower rate than the standard factor V.[6] Heterozygous FVL impacts 5% of Caucasians, predominantly Northern Europeans and Middle Easterners, although it is infrequently observed in Hispanics, Asians, Africans, and Native Americans.[2] Our patient is a South Indian individual identified with a heterozygous FVL mutation, indicating the inheritance of one copy of the FVL gene from one parent and one copy of the normal factor V gene from the other parent. The probability of PE escalates with the presence of many predisposing variables; hence, awareness of these factors is crucial.[7] Arthroscopic surgery is seen as lower risk compared to other orthopedic surgeries, including total joint replacement and trauma-related interventions. Despite the modest complication rates associated with arthroscopy, VTE problems, including DVT and PE, pose significant life-threatening risks and warrant urgent consideration.[1] In our case, arthroscopic ACL reconstruction was performed 1 week before the diagnosis of PE, which is a moderate predisposing factor. The patient did not adhere to the prescribed physiotherapy and opted for bed rest post-surgery, contrary to medical advice, which constitutes a significant predisposing factor.

The prodromal signs and symptoms of PE are predicated on hemodynamic instability and the compensatory mechanisms employed to rectify that instability. The signs and symptoms typically indicate clinical features of compromised pulmonary gas exchange and diminished cardiac output, including dyspnea, pleuritic chest discomfort, tachypnea, and tachycardia.[8] Regrettably, they exhibit inconsistency and frequently lack specificity. Our patient was admitted to the emergency department, presenting with severe dyspnea and altered mental status. Freeman.[9] determined that neither symptom nor physical finding exhibited a high positive predictive value for the diagnosis of PE. Stein et al.[10] showed that dyspnea, tachypnea, or pleuritic discomfort was observed in 92% of patients with PE.

Although day-care orthopedic and arthroscopic surgeries are generally safe, rare, potentially life-threatening complications can occur. These include PE due to DVT, fat embolism syndrome following long bone manipulation, anaphylaxis to drugs, and local anesthetic systemic toxicity, which may arise from accidental intravascular injection leading to seizures or cardiac arrest. Other critical risks include cardiac arrhythmias, air embolism – particularly during shoulder arthroscopy – compartment syndrome, and hemorrhagic shock from vascular injury. Infections may progress to sepsis and septic shock, while perioperative embolism can result in stroke. Elderly and obese individuals, as well as those with cardiac or thromboembolic histories, are at higher risk. Preventive measures such as thorough pre-operative assessment, DVT prophylaxis, strict aseptic technique, and vigilant perioperative monitoring are essential.

CONCLUSION

Our case underscores a rare but serious complication of arthroscopic ACL and MCL reconstruction – acute PE associated with heterozygous FVL mutation in a South Indian male patient with no prior history of thromboembolic risk factors. Early recognition of symptoms and adherence to postoperative physiotherapy are essential to prevent life-threatening complications. This case also emphasizes the importance of considering genetic testing in unexplained or severe thromboembolic events following orthopedic procedures, even in populations where such mutations are rare.

Highlights

  • First reported case of acute PE linked to heterozygous FVL mutation following arthroscopic ACL and MCL reconstruction in a South Indian patient.

  • The patient had no prior comorbidities or known risk factors for VTE before surgery.

  • The patient developed cardiac arrest and severe PE within 1 week postoperatively, requiring immediate ACLS and thrombolysis with tenecteplase.

  • Genetic analysis confirmed FVL heterozygosity, an uncommon finding in South Indian populations.

Acknowledgement:

We thank Orthopaedic consultants Dr. Akhil K Thomas, Dr Jithin CR and Clinical Pharmocologists Dr. Sarang P, Dr Ajinas T P, Dr.Mohamed Hadi Mansoor from Baby Memorial Hospital, Kannur, Kerala, India for their valuable support in the preparation of the manuscript.

Author contributions:

JM and VKS: Conceptualization, methodology, and supervision; VKS, AMC, and RAK: Contributed in preparation of the manuscript and literature search; JM and VKS: Revision of the article for the journal publication. All the authors have read and approved manuscript and each author believes that the manuscript represents honest work.

Ethical approval statement:

The Institutional Review Board approval is not required.

Declaration of patient consent:

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , , , . Bilateral pulmonary embolism after arthroscopic anterior cruciate ligament reconstruction: A case report. Int J Surg Case Rep. 2018;49:64-6.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , . Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost. 1998;24:367-79.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , . Deep venous thrombosis or pulmonary embolism and factor V Leiden: Enigma or paradox. Haematologica. 2010;95:863-6.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , . Complications following anterior cruciate ligament reconstruction in the English NHS. Knee. 2012;19:14-9.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , . Arterial complications, venous thromboembolism and deep venous thrombosis prophylaxis after anterior cruciate ligament reconstruction: A systematic review. World J Orthop. 2016;7:604-17.
    [CrossRef] [PubMed] [Google Scholar]
  6. , . Cardiology patient page. Factor V Leiden. Circulation. 2003;107:e94-7.
    [CrossRef] [PubMed] [Google Scholar]
  7. , . Risk factors for venous thromboembolism. Circulation. 2003;107:I9-16.
    [CrossRef] [Google Scholar]
  8. , , , . Pathophysiology and management of pulmonary embolism. Int J Angiol. 2022;31:143-9.
    [CrossRef] [PubMed] [Google Scholar]
  9. . Pulmonary embolism in a 13-year-old boy. Pediatr Emerg Care. 1999;15:422-4.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , , , et al. Clinical characteristics of patients with acute pulmonary embolism: Data from PIOPED II. Am J Med. 2007;120:871-9.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections